Clinical Case Scenario

at
Categories
Tags

 

1. During a case presentation at your clinic, you review four women with predisposing factors for osteoporosis. Which patient is least likely to be at risk for osteoporosis?
A. Nehineza, an overweight African American female with a family history of uterine cancer
B. Cristina, a Hispanic woman living a sedentary life
C. Park-Gim-Ka, an underweight Asian woman with a history of tobacco use
D. Skylar, a Caucasian woman experiencing early onset of menopause.
2. Densitometry results are given as T-scores. Which values would be considered osteopenia?
3. After prompt analysis of your patient, you decide to institute treatment for osteoporosis. Which class of medication is considered the first-line treatment? Are there any considerations to be made prior to starting therapy? Which recommendations would you provide to the patient regarding this treatment?

Sample Solution

Osteoporosis Case Review and Treatment

  1. Least Likely for Osteoporosis:

Among the patients presented, (A) Nehineza, an overweight African American female with a family history of uterine cancer is least likely to be at risk for osteoporosis.

Here’s why:

  • Race: African American and Hispanic women have a lower risk of osteoporosis compared to Caucasian and Asian women.
  • Body weight: Overweight individuals have a higher bone density due to increased mechanical stress on the bones.
  1. T-Scores for Osteopenia:

Densitometry results are reported as T-scores which indicate bone mineral density (BMD) compared to a healthy young adult. Here’s the breakdown:

  • Normal: T-score ≥ -1.0
  • Osteopenia: T-score between -1.0 and -2.5
  • Osteoporosis: T-score ≤ -2.5
  1. Osteoporosis Treatment:

First-line treatment: Bisphosphonates are the first-line medication class for osteoporosis treatment. Examples include alendronate (Fosamax) and risedronate (Actonel).

Considerations before starting therapy:

  • Bisphosphonates can cause esophageal irritation. Patients should take the medication with a full glass of water and remain upright for at least 30 minutes after ingestion.
  • Underlying kidney disease: Bisphosphonates may worsen kidney function, so kidney function tests are recommended before starting treatment.
  • Dental health: Bisphosphonates have been linked to a rare complication called osteonecrosis of the jaw (ONJ). Patients with poor dental hygiene or upcoming dental procedures may require a dental evaluation before starting therapy.

Recommendations for the patient:

  • Calcium and Vitamin D supplementation: These are crucial for bone health and are often recommended alongside bisphosphonates.
  • Weight-bearing exercise: Regular weight-bearing exercises like walking, jogging, or dancing can help maintain bone density.
  • Diet: A balanced diet rich in calcium and vitamin D is recommended.
  • Regular follow-up: Schedule regular appointments with your doctor to monitor the effectiveness of treatment and perform bone density scans periodically.

 

This question has been answered.

Get Answer